Pharmaleads PL37 yields positive data
PL37 belongs to Dual ENKephalinase Inhibitors (DENKI), a class of painkillers, which targets peripheral pain, of neuropathic and osteoarthritic origin in particular, by oral route as well as
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.
The approval has been confirmed for the UK, Belgium, Finland, Ireland, Luxemburg, Netherlands and Sweden. Octapharma’s manufacturing process for OctaplasLG, which is a solvent/detergent treated, prion-reduced, plasma product